Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000698781 | SCV000827467 | pathogenic | Tumor predisposition syndrome 3 | 2021-08-04 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 576311). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with POT1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln358Asnfs*9) in the POT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in POT1 are known to be pathogenic (PMID: 32155570). |
The Telomere Center at Johns Hopkins, |
RCV003329328 | SCV003853315 | pathogenic | Long telomere syndrome | 2022-08-01 | no assertion criteria provided | clinical testing |